Latest Biotech Startup Funding Rounds

Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.

This page showsSector: Biotech
Rounds
477
Jan 1 – Oct 25, 2026
Disclosed funding
$20.2B
403 disclosed amounts
Median round
$20M
Of disclosed amounts
477 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
MindImmuneBiotech · United StatesCompany profile

Develops immune-focused therapies for neurodegenerative diseases, including Alzheimer’s disease

Develops immune-focused therapies for neurodegenerative diseases, including Alzheimer’s disease

$5MStrategicUndisclosedBiotechUnited StatesInvestors
CytotraitAgritech · United KingdomCompany profile

Develops crop engineering technology for precise gene editing in plant organelles

Develops crop engineering technology for precise gene editing in plant organelles

£3MSeedBiotech, AgritechUnited KingdomInvestors
Science CorporationHealthtech · United StatesCompany profile

Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases

Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases

$230MSeries CSeries C+Biotech, HealthtechUnited StatesInvestors
Cellbox SolutionsBiotech · GermanyCompany profile

Cellbox Solutions provides portable incubators and warm-chain logistics services for transporting living biological materials.

Cellbox Solutions provides portable incubators and warm-chain logistics services for transporting living biological materials.

€5MSeries A — €5m final close October 2026Series ABiotechGermanyInvestors
NexCureHealthtech · United StatesCompany profile

Provides CAR-T and other advanced treatment delivery in community outpatient settings

Provides CAR-T and other advanced treatment delivery in community outpatient settings

$19MSeries ABiotech, HealthtechUnited StatesInvestors
AntheiaBiotech · United StatesCompany profile

Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients.

Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients.

$9MBioMaP project agreement expansionUndisclosedBiotechUnited StatesInvestors
Undisclosed
Alithea GenomicsBiotech · SwitzerlandCompany profile

Alithea Genomics supplies RNA-sequencing preparation kits and services for laboratories running large gene-expression and drug-screening studies.

Alithea Genomics supplies RNA-sequencing preparation kits and services for laboratories running large gene-expression and drug-screening studies.

CHF 3MSeedBiotechSwitzerlandInvestors
ShellworksClimate tech · United KingdomCompany profile

Develops bio-based plastic alternative materials for packaging and consumer goods

Develops bio-based plastic alternative materials for packaging and consumer goods

$15MSeries ABiotech, Climate techUnited KingdomInvestors
MycoverseAgritech · DenmarkCompany profile

Developing fungal-based biological crop protection solutions using AI-driven discovery platform

Developing fungal-based biological crop protection solutions using AI-driven discovery platform

€2.4MPre-SeedPre-seedBiotech, AgritechDenmarkInvestors
Poplar TherapeuticsBiotech · United StatesCompany profile

Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions

Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions

$45MSeries A+Series ABiotechUnited StatesInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · From Jan 1, 2026

  1. 1
    RA Capital Management

    Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology

    23rounds
    3led
  2. 2
    Janus Henderson Investors

    Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics

    15rounds
    1led
  3. 3
    Eli Lilly and Company

    BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences

    15rounds
    0led
  4. 4
    ARCH Venture Partners

    Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences

    14rounds
    0led
  5. 5
    OrbiMed

    Star Therapeutics, Leal Therapeutics, Accro Bioscience

    11rounds
    1led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic